TASCINI, Carlo
 Distribuzione geografica
Continente #
AS - Asia 8.434
NA - Nord America 8.068
EU - Europa 3.905
SA - Sud America 1.854
AF - Africa 233
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 7
Totale 22.518
Nazione #
US - Stati Uniti d'America 7.839
SG - Singapore 4.502
BR - Brasile 1.517
IT - Italia 1.413
CN - Cina 1.211
HK - Hong Kong 981
VN - Vietnam 787
RU - Federazione Russa 466
FR - Francia 398
DE - Germania 308
IE - Irlanda 305
IN - India 220
GB - Regno Unito 181
FI - Finlandia 176
UA - Ucraina 134
AR - Argentina 123
SE - Svezia 110
BD - Bangladesh 100
CA - Canada 98
TR - Turchia 85
KR - Corea 81
AT - Austria 80
MX - Messico 79
IQ - Iraq 70
ZA - Sudafrica 70
NL - Olanda 69
ID - Indonesia 65
EC - Ecuador 58
JP - Giappone 54
ES - Italia 49
PL - Polonia 48
CO - Colombia 45
PK - Pakistan 43
MA - Marocco 34
BE - Belgio 27
UZ - Uzbekistan 25
VE - Venezuela 25
CL - Cile 23
SA - Arabia Saudita 22
PE - Perù 21
PY - Paraguay 19
TG - Togo 19
TN - Tunisia 18
CH - Svizzera 17
JO - Giordania 17
EG - Egitto 16
KE - Kenya 16
LT - Lituania 14
NP - Nepal 14
PH - Filippine 14
DZ - Algeria 13
LB - Libano 13
AE - Emirati Arabi Uniti 11
AZ - Azerbaigian 11
TW - Taiwan 11
UY - Uruguay 11
AL - Albania 10
CZ - Repubblica Ceca 10
IL - Israele 10
AU - Australia 9
BO - Bolivia 9
HR - Croazia 9
KZ - Kazakistan 9
OM - Oman 9
PT - Portogallo 9
BG - Bulgaria 8
DO - Repubblica Dominicana 8
GR - Grecia 8
LV - Lettonia 8
CR - Costa Rica 7
KG - Kirghizistan 7
PA - Panama 7
RO - Romania 7
TH - Thailandia 7
CI - Costa d'Avorio 6
ET - Etiopia 6
GE - Georgia 6
HU - Ungheria 6
JM - Giamaica 6
RS - Serbia 6
AO - Angola 5
BH - Bahrain 5
BY - Bielorussia 5
DK - Danimarca 5
MY - Malesia 5
SY - Repubblica araba siriana 5
AM - Armenia 4
BB - Barbados 4
BZ - Belize 4
KH - Cambogia 4
KW - Kuwait 4
LK - Sri Lanka 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
PS - Palestinian Territory 4
EU - Europa 3
GT - Guatemala 3
MD - Moldavia 3
NI - Nicaragua 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 22.444
Città #
Singapore 1.627
Hong Kong 961
Ashburn 934
Beijing 493
San Jose 468
Chandler 464
Redmond 384
Boardman 365
Lauterbourg 313
Fairfield 307
Dublin 287
Woodbridge 281
Ho Chi Minh City 266
Wilmington 252
Princeton 245
Dallas 239
Houston 220
Los Angeles 206
Ann Arbor 180
Udine 176
Redondo Beach 148
Seattle 143
Hanoi 140
Council Bluffs 131
Cambridge 129
São Paulo 127
Buffalo 122
Milan 105
Helsinki 96
Mumbai 89
New York 86
Hefei 85
Seoul 78
Dong Ket 76
Rome 74
Munich 68
Frankfurt am Main 66
Nuremberg 65
The Dalles 64
Santa Clara 61
Belluno 56
Jacksonville 53
Dearborn 52
Tokyo 51
Norwalk 44
Chicago 43
Rio de Janeiro 43
Johannesburg 42
Lappeenranta 41
Vienna 40
Izmir 39
Montreal 38
Orem 35
Trieste 35
Warsaw 35
Belo Horizonte 34
Ogden 34
San Diego 32
Brasília 31
Mexico City 31
Amsterdam 30
Atlanta 30
Denver 30
Florence 30
Guangzhou 29
Da Nang 27
Haiphong 27
London 27
Naples 26
Phoenix 26
Des Moines 25
Brussels 24
Baghdad 23
Bologna 23
Brooklyn 23
Turku 23
Chennai 22
Curitiba 22
Porto Alegre 22
Dhaka 21
Düsseldorf 21
Stockholm 21
Tashkent 21
Poplar 20
Lomé 19
Buenos Aires 18
Quito 18
Toronto 18
Venice 18
Hyderabad 17
Manchester 17
Washington 17
Biên Hòa 16
Bogotá 16
Boston 16
Guarulhos 16
Hải Dương 16
Campinas 15
Casablanca 15
Guayaquil 15
Totale 12.290
Nome #
Lessons learnt while designing and conducting a longitudinal study from the first Italian COVID-19 pandemic wave up to 3 years 281
Exploring ecological modelling to investigate factors governing the colonization success in nosocomial environment of Candida albicans and other pathogenic yeasts 242
A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. 214
Gestione Diagnostico-Terapeutica del Paziente di Area Critica con Infezione Grave da Patogeni Batterici Multiresistenti 200
MR-proADM as prognostic factor of outcome in COVID-19 patients 188
Ceftolozane/tazobactam for the treatment of serious P. aeruginosa infections: a multicenter nationwide clinical experience 182
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 182
A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality 179
An Italian consensus for invasive candidiasis management (ITALIC) 171
Variable incidence of candidemia in patients admitted to ICUs or medical wards of large tertiary-care Italian hospitals 170
Risk factors associated with the onset of daptomycin non-susceptibility in Staphylococcus aureus infections in critically ill patients 163
Ampicillin and Ceftobiprole Combination for the Treatment of Enterococcus faecalis Invasive Infections: “The Times They Are A-Changin” 156
Linezolid-resistant staphylococcal bacteraemia: A multicentre case-case-control study in Italy 153
Independent risk factors for mortality in critically ill patients with candidemia on Italian Internal Medicine Wards 149
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 148
MEDical wards Invasive Candidiasis ALgorithms (MEDICAL):Consensus proposal for management 148
Lung Ultrasound Signs and Their Correlation With Clinical Symptoms in COVID-19 Pregnant Women: The “PINK-CO” Observational Study 145
Predictors of choice of initial antifungal treatment in intraabdominal candidiasis 141
Hyposmia and Dysgeusia in COVID-19: Indication to Swab Test and Clue of CNS Involvement 141
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care 139
Combining Deep Phenotyping of Serum Proteomics and Clinical Data via Machine Learning for COVID-19 Biomarker Discovery 130
Micafungin for the treatment of proven and suspected invasive candidiasis in children and adults: Findings from a multicenter prospective observational study 129
The role of biofilm forming on mortality in patients with candidemia: a study derived from real world data 128
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis 125
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study 124
The Fall in Antibody Response to SARS-CoV-2: A Longitudinal Study of Asymptomatic to Critically Ill Patients up to 10 Months after Recovery 124
Population pharmacokinetics and pharmacodynamic target attainment of isavuconazole against aspergillus fumigatus and aspergillus flavus in adult patients with invasive fungal diseases: Should therapeutic drug monitoring for isavuconazole be considered as mandatory as for the other mold-active azoles? 124
Ceftobiprole: drug evaluation and place in therapy 121
Eravacycline: Data Based on Real Evidence 119
Low risk of reinfections and relation with serological response after recovery from the first wave of COVID-19 119
Mental health symptoms one year after acute COVID-19 infection: prevalence and risk factors 119
Vaccine Hesitancy among Italian Patients Recovered from COVID-19 Infection towards Influenza and Sars-Cov-2 Vaccination 118
Detection of SARS-CoV-2 infection prevalence in 860 cancer patients with a combined screening procedure including triage, molecular nasopharyngeal swabs and rapid serological test. A report from the first epidemic wave 117
INFEZIONI da GRAM POSITIVI per QUADRO SINDROMICO Dal laboratorio alla clinica 116
Risk factors for ventilator associated pneumonia due to carbapenemase-producing Klebsiella pneumoniae in mechanically ventilated patients with tracheal and rectal colonization 113
A cluster of COVID-19 cases in a small Italian town: a successful example of contact tracing and swab collection 112
Acid-suppressant therapy does not influence absorption of azoles used in candidemia 111
KPC-producing Klebsiella pneumoniae gut decolonisation following ceftazidime/avibactam-based combination therapy: A retrospective observational study 110
Covid-19 and the role of smoking: the protocol of the multicentric prospective study COSMO-IT (COvid19 and SMOking in ITaly). 110
Post–COVID-19 syndrome and humoral response association after 1 year in vaccinated and unvaccinated patients 110
Cytokines from Bench to Bedside: A Retrospective Study Identifies a Definite Panel of Biomarkers to Early Assess the Risk of Negative Outcome in COVID-19 Patients 109
Risk factors and outcome of c. Difficile infection after hematopoietic stem cell transplantation 108
Screening procedure for SARS-CoV-2 infection combining triage, nasopharyngeal swab and serological test in allogeneic stem cell transplantation recipients undergoing outpatient posttransplant follow-up 107
Reading and understanding an antibiogram 106
One Word to Describe My Experience as a COVID-19 Survivor Six Months after Its Onset: Findings of a Qualitative Study 106
Candidemia in Patients with Body Temperature Below 37°C and Admitted to Internal Medicine Wards: Assessment of Risk Factors 105
Use of colistin in adult patients: A cross-sectional study 105
Clinical presentation and immunological features of Post-Malaria Neurologic Syndrome: a case report and review of literature 105
L'uso dei farmaci antimicrobici in terapia intensiva - Letteratura ragionata dell'antibiogramma 105
Higher levels of IL-6 early after tocilizumab distinguish survivors from non-survivors in COVID-19 pneumonia: a possible indication for deeper targeting IL-6 104
Prognostic role of malnutrition diagnosed by bioelectrical impedance vector analysis in older adults hospitalized with covid-19 pneumonia: A prospective study 104
Echocardiographic Comparison of COVID-19 Patients with or without Prior Biochemical Evidence of Cardiac Injury after Recovery 103
The impact of body composition on mortality of COVID-19 hospitalized patients: A prospective study on abdominal fat, obesity paradox and sarcopenia 102
A Randomized Controlled Trial to Examine the Efficacy and Safety of a New Super-Oxidized Solution for the Management of Wide Postsurgical Lesions of the Diabetic Foot 100
Local occurrence and fast spread of B.1.1.7 lineage: A glimpse into Friuli Venezia Giulia 100
Safety and effcacy of subcutaneous administration of Beta-Lactams: a Systematic Review and Meta-analysis. (In: The 20th European Doctoral Conference in Nursing Science – EDCNS) 98
Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients 98
Validation of a Saliva-Based Test for the Molecular Diagnosis of SARS-CoV-2 Infection 98
Extracellular vesicle features are associated with COVID-19 severity 97
A Novel Immunosuppressive Strategy Combined with Preemptive Antiviral Therapy Improves the Eighteen-Month Mortality in HCV Recipients Transplanted with Aged Livers 94
Enterobacterales multiresistenti - Dal laboratorio alla clinica 93
A single-staggered dose of calcineurin inhibitor may be associated with neurotoxicity and nephrotoxicity immediately after liver transplantation 93
A Global Declaration on Appropriate Use of Antimicrobial Agents across the Surgical Pathway 93
Ventilatory associated barotrauma in COVID-19 patients: A multicenter observational case control study (COVI-MIX-study) 92
D-Dimer as Biomarker for Early Prediction of Clinical Outcomes in Patients With Severe Invasive Infections Due to Streptococcus Pneumoniae and Neisseria Meningitidis 92
A prediction rule for early recognition of patients with candidemia in Internal Medicine: results from an Italian, multicentric, case-control study 91
Cefditoren: a clinical overview 90
Antibody response and risk of reinfection over 2 years among the patients with first wave of COVID-19 90
Persistence of fatigue in the absence of pathophysiological mechanisms in some patients more than 2 years after the original SARS-CoV-2 infection 86
Renal Function and Its Impact on the Concentration of Ceftazidime-Avibactam: A cross-sectional study 86
Blood ozonization in patients with mild to moderate COVID-19 pneumonia: a single centre experience 86
Accuracy of point-of-care ultrasound to identify the source of infection in septic patients: a prospective study-comment 86
Mid-regional pro-adrenomedullin as a supplementary tool to clinical parameters in cases of suspicion of infection in the emergency department 86
COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomes 85
L’interpretazione del fenotipo antibiotico come strumento per il clinico. 85
2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS 85
Longest incubation period of Mycobacterium chimaera infection after cardiac surgery 85
Mono vs. combo regimens with novel beta-lactam/beta-lactamase inhibitor combinations for the treatment of infections due to carbapenemase-producing Enterobacterales: insights from the literature 84
L'uso dei Farmaci Antifungini nel Paziente Critico. Le Infezioni Fungine nel Paziente Critico dal Laboratorio alla Clinica per Ottimizzare la Diagnosi e la Terapia 84
PK/PD Analysis of High-Dose Daptomycin Use in the Treatment of Bone and Joint Infections: Data from a Real-World Setting 84
COVID-19 Survivors Are Still in Need of Neuropsychiatric Support Two Years after Infection 83
A Rapid High-Performance Liquid Chromatography Method to Measure Linezolid and Daptomycin Concentrations in Human Plasma 83
A NEW IMMUNOSUPPRESSIVE STRATEGY COMBINED WITH EARLY ANTIVIRAL THERAPY IMPROVES SURVIVAL AND LEADS TO HCV ERADICATION AT THE SAME COST OF THE HBV PROPHYLAXIS 3 YEARS AFTER LIVER TRANSPLANTATION 83
Monitoring the SPREAD of the SARS-CoV-2 lineage B.1.621 in Udine, Italy 83
Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality 82
Approach to patients with COVID-19 disease: The procedure in Udine 82
Barotrauma during Noninvasive Respiratory Support in COVID-19 Pneumonia Outside ICU: The Ancillary COVIMIX-2 Study 81
Liposome composition of colistin for intravenous, oral, and cutaneous therapheutic use, and process for its preparation 81
A dangerous job 80
Pragmatic overview on acute bacterial and fungal infections of the central nervous system: a holistic update from diagnosis to treatment 79
A Position Paper on IgM-Enriched Intravenous Immunoglobulin Adjunctive Therapy in Severe Acute Bacterial Infections: The TO-PIRO SCORE Proposal 79
European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 79
A proposal for distinguishing between bacterial and viral meningitis using genetic programming and decision trees 79
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 78
The Subcutaneous Administration of Beta-Lactams: A Case Report and Literary Review—To Do Small Things in a Great Way 77
Relationship between cytokine release and stress hyperglycemia in patients hospitalized with COVID-19 infection 76
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome 76
A neglected outbreak in a long-term care facility: Scabies 76
Authors’ Reply to Cattaneo et al.: “Comment on: Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin6” 76
A case report of treatment of a streptococcal brain abscess with ceftobiprole supported by the measurement of drug levels in the cerebrospinal fluid 76
Totale 11.270
Categoria #
all - tutte 118.911
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.911


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021338 0 0 0 0 0 0 0 0 0 99 124 115
2021/20221.478 78 78 74 50 85 31 52 105 95 222 331 277
2022/20231.506 271 124 21 141 121 410 47 70 168 15 65 53
2023/2024922 102 46 60 52 98 108 41 147 59 83 37 89
2024/20255.961 143 364 215 250 136 263 403 309 837 519 966 1.556
2025/202610.674 831 1.277 1.238 1.433 1.728 968 1.447 472 632 648 0 0
Totale 23.874